Typhus Fever (Rickettsia) Antibodies IgG & IgM Test in UAE | 1,800 AED | DHA Licensed

Executive Summary & Core Metrics

✔ Diagnostic Accuracy: 99.9% clinical sensitivity via ISO 15189-accredited immunofluorescence assay with visual endpoint titration.
✔ Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
✔ Clinical Guidance: Post-test telephone consultation for result interpretation by a DHA-licensed General Practitioner.
✔ Insurance Verification: Direct coverage check via WhatsApp at +971 54 548 8731.

Test Overview & Methodology

This serological panel detects IgG and IgM antibodies against Rickettsia species using the gold-standard Immunofluorescence Assay (IFA) with visual endpoint titration. The test delivers definitive differentiation between past exposure and acute typhus infection. In the UAE, where tick‑borne diseases may be under‑recognised, this send‑out panel provides a crucial diagnostic window with a 2–3 week turnaround due to specimen batching at the reference laboratory. The semi‑quantitative titer results guide clinicians in diagnosing epidemic, murine, or scrub typhus.

Parameter	Our Test (IFA)	Closest Alternative (EIA)
Methodology	Immunofluorescence Assay (IFA) – visual endpoint titration	Enzyme Immunoassay (EIA)
Diagnostic Sensitivity	>98% for IgG; >95% for IgM (confirmed by paired sera)	~90% sensitivity, cross‑reactivity risk
Turnaround Time	2–3 weeks (batched send‑out)	Often 5–7 days (local lab)
UAE DHA Acceptance	Fully compliant (ISO 15189 referral lab)	May require confirmatory IFA

Physician Insight & Safety Protocols

“As a DHA-licensed General Practitioner, I stress that serological results must be interpreted alongside clinical presentation and epidemiological history. A single positive IgG cannot distinguish past exposure from active infection; paired acute and convalescent sera demonstrating a fourfold rise in titer provides definitive evidence. Always correlate with your treating clinician.”

— Dr. Ajay Singh, General Practitioner, DHA Registration ID: 36234132

Advisory: Medication & Antibiotic Therapy

Do not discontinue any prescribed medication without consulting your doctor. Antibiotic therapy initiated prior to sample collection may reduce antibody response and should be clearly documented on the test requisition form to avoid misinterpretation of results.

Exclusion Criteria & Emergency Red Flags

Exclusion: Incomplete Test Send Out Consent Form (Form 35) – sample will be rejected.
Exclusion: Hemolyzed, lipemic, or microbially contaminated serum specimens.
Seek immediate emergency care (ER) if you experience: Severe persistent headache, high fever (>39.5°C) unresponsive to antipyretics, confusion, neck stiffness, or petechial rash.

Patient FAQ & Clinical Guidance

1. What exactly does the Typhus Fever (Rickettsia) IgG & IgM test measure?

This panel measures immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies specific to Rickettsia species in your serum, distinguishing an acute infection (IgM positive) from past exposure or convalescence (IgG positive). The immunofluorescence assay uses fluorescence-labelled antigens to visualise and titre antibody binding, providing a semi-quantitative result that guides clinicians in diagnosing epidemic, murine, or scrub typhus.

2. Why does the test require 2–3 weeks for results, and is there a faster option?

The specimen must be batched and shipped to a reference laboratory for manual immunofluorescence assay, which involves multiple incubation steps and expert microscopic reading, resulting in a standard turnaround of 2–3 weeks. Faster serological EIA tests exist but lack the specificity required for definitive typhus diagnosis and are not accepted by UAE health authorities without IFA confirmation; no in‑house rapid alternative equals the gold‑standard sensitivity of this send‑out IFA.

3. How is the sample collected and what preparation is needed?

A trained phlebotomist collects 2 mL (1 mL minimum) of venous blood into a serum separator tube (SST) during a home or clinic visit; the sample must be shipped refrigerated or frozen. You must sign the mandatory Test Send Out Consent Form (Form 35) acknowledging the send‑out logistics and extended reporting time. No fasting or medication cessation is required unless specifically instructed by your physician.

UAE Regulatory & Data Privacy Adherence

Data Protection & Health Information Governance: All patient data handling complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Laboratory processing is performed under ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) and ISO 15189 accredited partner laboratories.

Corporate Lab Branding: DNA Labs UAE | DHA Facility License Number: 1143 | Physical Address: Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | WhatsApp Support: +971 54 548 8731

Clinical & Logistical Metadata

Test Name	Typhus Fever (Rickettsia) Antibodies IgG & IgM
Price (AED)	1,800 AED
Turnaround Time	2–3 weeks (batched send‑out to reference laboratory)
Sample Type / Matrix	Serum (venous blood) – 2 mL in SST; refrigerated or frozen cold‑chain transport
Methodology Used	Immunofluorescence Assay (IFA) with visual endpoint titration
ICD-10-CM Code	A75.9 (Typhus fever, unspecified), A75.2 (Typhus fever due to Rickettsia typhi), A75.0 (Epidemic louse‑borne typhus)
LOINC Code	94587-0 (Rickettsia IgG and IgM panel – Serum by Immunofluorescence)
DHA Facility License & Address	License No. 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE \| DNA Labs UAE